8-epi-prostaglandin-f2alpha and Skin-Neoplasms

8-epi-prostaglandin-f2alpha has been researched along with Skin-Neoplasms* in 2 studies

Trials

1 trial(s) available for 8-epi-prostaglandin-f2alpha and Skin-Neoplasms

ArticleYear
High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy.
    BioMed research international, 2015, Volume: 2015

    Phase I of this study was aimed at comparing the profiles of oxidative stress biomarkers in patients with history of nonmelanoma skin cancer (NMSC), previously treated with surgery, to the healthy subjects. Phase II aimed to evaluate the effects of supplementary antioxidant therapy on the levels of biomarkers in the case group.. In Phase I, oxidative stress biomarkers were measured in blood samples obtained from 24 healthy subjects and 60 patients with history of NMSC previously treated with surgery. In Phase II, the 60 patients with history of NMSC were randomized into two subgroups, one receiving placebo (n = 34) and the other (n = 26) receiving vitamin C, vitamin E, and zinc supplementation for 8 weeks, followed by reevaluation of biomarkers.. In Phase I, patients with history of NMSC showed increased plasma concentrations of all biomarkers, but only 15-F2t-isoprostane was significantly higher than in the healthy subjects. Risk of NMSC increased by 4% for each additional 1 pg/mL increase in 15-F2t-isoprostane. In Phase II, supplementation did not significantly reduce levels of oxidative stress biomarkers.. Patients with history of NMSC had significantly high 15-F2t-isoprostane plasma levels; supplementation did not result in significant reduction of oxidative stress biomarkers. This trial was registered with ClinicalTrials.gov (ID NCT02248584).

    Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Biomarkers, Tumor; Dietary Supplements; Dinoprost; Female; Humans; Isoprostanes; Male; Middle Aged; Oxidative Stress; Skin Neoplasms; Vitamin E; Zinc

2015

Other Studies

1 other study(ies) available for 8-epi-prostaglandin-f2alpha and Skin-Neoplasms

ArticleYear
The topical application of 2,3,7,8-tetrachlorodibenzo-p-dioxin lacks skin tumor-promoting potency but induces hepatic injury and tumor necrosis factor-alpha expression in ICR male mice.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2004, Volume: 42, Issue:8

    One of the most toxic environmental pollutants known to man is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). There is growing evidence that indicates TCDD is a potent tumor promoter in rat and mouse liver, as well as in mouse skin. The mouse skin carcinogenesis model has been used extensively to assess whether a chemical or physical agent carries a carcinogenic hazard to humans and to define the mechanism involved with the carcinogenic effects. We applied the mouse skin model to ICR male mice and the results showed that following the application of DMBA, repeated dorsal application of all doses of TCDD produced no papillomas. These findings imply that the ICR male mouse is an extremely insensitive strain as a TCDD-induced two-stage mouse skin carcinogenesis model. However, severe hepatic injuries and wasting syndrome were seen in mice treated topically with TCDD. Meanwhile, serum TNF-alpha levels increased during the experimental periods. Inflammatory cell infiltration, fatty liver, and nodule formation could be observed in damaged livers. Elevated hepatic EROD activity and urinary 8-epi-PGF2alpha were also observed in mice with short-term exposure of TCDD.

    Topics: Administration, Topical; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP1A1; Dinoprost; Environmental Pollutants; Immunohistochemistry; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Polychlorinated Dibenzodioxins; Proliferating Cell Nuclear Antigen; Skin Neoplasms; Tumor Necrosis Factor-alpha

2004